Carol G. Gallagher, Pharm. D., has been named vice president, commercial affairs, at Anadys Pharmaceuticals. Dr. Gallagher will be responsible for commercial affairs, including business development, market planning and strategic planning. “We are very pleased that Carol is joining Anadys,” said Kleanthis G. Xanthopoulos, Ph.D., Anadys’ president and chief executive officer. “Her leadership and experience in managing many therapeutic agents with multiple partners on a worl...